¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19
±³À°ÀÏÀÚ : 2024-05-19
±³À°Àå¼Ò : "°¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ"

±³À°ÁÖÁ¦ : "Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ"

ÁÖÃÖ±â°ü : ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼö¸éÈ£ÈíÇÐȸ

´ã´çÀÚ : ´ëÇѼö¸éÈ£ÈíÇÐȸ
¿¬¶ôó : 031-787-7420

À̸ÞÀÏ : sleepbreathing@gmail.com

±³À°Á¾·ù : À̺ñÀÎÈÄ°ú

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 100,000¿ø  

ºñ°í "ȸ¿ø(ȸºñ³³ºÎ) : Àü¹®ÀÇ(Æò»ýȸ¿ø) - 40,000¿ø / Àü¹®ÀÇ(Á¤È¸¿ø) - 40,000¿ø / Àü°øÀÇ(ÁØȸ¿ø) - 30,000¿ø / ÀϹÝȸ¿ø - 40,000¿ø / ¿ø·Îȸ¿ø - 40,000¿ø

ȸ¿ø(ȸºñ¹Ì³³) : Àü¹®ÀÇ(Æò»ýȸ¿ø) - 100,000¿ø / Àü¹®ÀÇ(Á¤È¸¿ø) - 100,000¿ø / Àü°øÀÇ(ÁØȸ¿ø) - 30,000¿ø / ÀϹÝȸ¿ø - 100,000¿ø /  ¿ø·Îȸ¿ø - 100,000¿ø  

ºñȸ¿ø : Àü¹®ÀÇ(ºñȸ¿ø) - 100,000¿ø / Àü°øÀÇ(ºñȸ¿ø) - 30,000¿ø / ÀÇ·á±â»ç - 100,000¿ø / Çлý - 30,000¿ø / ±âŸ - 30,000¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 08:30~08:45 Predictors for short-term and long-term automatic PAP compliance (JCSM) ¹Ú¼ÛÀÌ(ÀÏ»ê¹éº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 08:45~09:00 The accuracy and difference of scoring rules and methods to score respiratory event-related leg movements in obstructive sleep apnea patients (Sleep Medicine) °­À±Áø(¼øõÇâ´ë õ¾Èº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 09:00~09:15 Patients with Epiglottic Collapse Are Less Adherent to Autotitrating Positive Airway Pressure Therapy for Obstructive Sleep Apnea (Annals ATS) ¾çÇüä(Àü³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 09:15~09:30 Predicting obstructive sleep apnea based on computed tomography scan using deep learning models (AJRCCM) ±èÁø¿±(µ¿±¹´ë Àϻ꺴¿ø)

±âŸ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 09:30~09:40 Opening remark ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 09:40~10:10 Disruptors-to-be in sleep medicine: My personal experience ±èÁ¤ÈÆ(ºÐ´ç¼­¿ï´ëº´¿ø)

ÈÞ½Ä 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 10:10~10:25 Break ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 10:25~10:45 Is apnea-hypopnea index (AHI) the best marker of OSA? ÃÖÁöÈ£(¼øõÇâ´ë ºÎõº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 10:45~11:05 Effect of chronic intermittent hypoxia on systemic disease ¹Úµµ¾ç(¾ÆÁִ뺴¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 11:05~11:25 PSG markers associated with long-term survival effect È«¼®Áø(°­ºÏ»ï¼ºº´¿ø)

Åä·Ð 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 11:25~11:35 Q&A ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 11:35~11:55 ¾ç¾Ð±â ó¹æ µî 2024³â¿¡ ´Þ¶óÁø º¸Çè °ü·Ã issueµé °íÅ°æ(ºÎ»ê¼º¸ðº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 11:55~12:15 Oral appliance º¸Çè Àû¿ë°ú HGN stimulation ±¹³» µµÀÔ °¡´É¼º ¹Ú¼ö°æ(Ãæ³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 12:15~12:35 OSA ȯÀÚ Áø·á¸¦ À§ÇÑ Æò°¡ ¹× °Ë»ç ó¹æ ÇÁ·ÎÅäÄÝ Á¤¿ë±â(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 12:35~12:45 Q&A ( )

½Ä»ç 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 12:45~13:35 Lunch ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 13:35~13:55 Co-morbid OSA and insomnia (COMISA) ¼Û±âÀç(°¡Å縯°üµ¿´ë)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 13:55~14:15 Central apnea Á¶À翵(¼­¿ï´ëº´¿ø È£Èí±â³»°ú)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 14:15~14:35 Restless legs syndrome (RLS) and periodic limb movements during sleep (PLMS) ¼±¿ìÁØ»ó(°­ºÏ»ï¼ºº´¿ø ½Å°æ°ú)

Åä·Ð 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 14:35~14:45 Q&A ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 14:45~15:00 Meta-analysisÀ» ÅëÇØ ÀÌÇØÇÏ´Â ¼ö¸é¹«È£ÈíÀÇ º´Å»ý¸® ¼ºÃ游(Àü³²´ëº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 15:00~15:15 ¿ì¸®°¡ »ç¿ëÇÏ´Â ¼ö¸é¹«È£ÈíÁõ Áø´Ü¹ý °£ÀÇ ±Ù°Å ºñ±³ ¹ÚÁöȯ(ºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 15:15~15:30 ¼ö¸é¹«È£ÈíÁõ Ä¡·á¹ýÀÇ È¿°ú´Â ¾ó¸¶³ª È®½ÇÇÒ±î? ÀÌ¿µÇÏ(¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø)

Åä·Ð 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 15:30~15:40 Q&A ( )

ÈÞ½Ä 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 15:40~15:55 Break ( )

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 15:55~16:10 The effect of treating rhinitis on OSA ÀÌÀºÁ¤(¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 16:10~16:25 The effect of septoplasty and/or rhinoplasty on patients with OSA ¹Ú¸¸ÁØ(ÀÎÇϴ뺴¿ø)

±³À°½Ã°£ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 16:25~16:40 The effect of treating CRS on OSA À¯½ÅÇõ(´Ü±¹´ëº´¿ø)

Åä·Ð 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 16:40~16:50 Q&A ( )

±âŸ 05¿ù 19ÀÏ ¸¶¸®¾ÆȦ 16:50~17:00 ÃÑȸ ÈÄ Æóȸ ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19
´ÙÀ½±Û 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20544 ¼­¿ï 2024 Çѱ¹¸ðÀÚº¸°ÇÇÐȸ Á¦54ȸ Ãá°è¿¬¼ö°­Á : 2024-05-25 0 26 2024-04-29
20543 ¼­¿ï Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ Áö¿ª»çȸ ±â¹Ý ÀÇ·á¿Í À±¸®¿ª·® °­È­ : 2024-05-25 0 30 2024-04-29
20542 °­¿ø Á¦31Â÷ ´ëÇѽŰæ¼Õ»óÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-25 0 55 2024-04-29
20541 Ãæ³² Á¦4ȸ ´ëÇѺñ¸¸ÇÐȸ ÃæûÁöȸ ¿¬¼ö°­Á : 2024-05-25 0 72 2024-04-29
20540 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ ¿¬ÇÕ ½ÉÆ÷Áö¾ö : 2024-05-25 0 40 2024-04-29
20539 ¼­¿ï 2024 ÀÎÁöÁßÀçÄ¡·áÇÐȸ Ãá°è Çмú´ëȸ : 2024-05-25 0 51 2024-04-29
20538 ¼­¿ï Á¦8ȸ °­µ¿°æÈñ´ëÇб³º´¿ø ÀÓ»óÀǸ¦ À§ÇÑ ½Å°æ°ú ¿¬¼ö°­Á : 2024-05-25 0 50 2024-04-29
20537 °æºÏ 2024³âµµ °æ»óºÏµµÀÇ»çȸ Á¾ÇÕÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-25 0 46 2024-04-29
20536 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 56 2024-04-29
20535 Àü³² Á¦56ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ day 2 : 2024-05-24 0 44 2024-04-29
20534 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-05-24 0 36 2024-04-29
20533 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(À§¿øȸ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-05-24 0 38 2024-04-29
20532 Àü³² 2024³â ¼øõ½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ(ºÎÁ¤¸Æ, ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý) : 2024-05-23 0 53 2024-04-29
20531 Àü³² Á¦56ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-23 0 55 2024-04-29
20530 ¼­¿ï ¿¡ÀÌÄ¡Ç÷¯½º¾çÁöº´¿ø Á¦2024-1ȸ ¿¬¼ö°­Á : 2024-05-23 0 47 2024-04-29
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷